NCT03894878View on ClinicalTrials.gov

Association Between Genetic Variant Scores and Warfarin Effect

CompletedOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

February 11, 2019

Primary Completion Date

September 30, 2022

Study Completion Date

September 30, 2022

Conditions

Atrial FibrillationDeep Vein ThrombosisIntracardiac ThrombusPulmonary EmbolismVenous Thromboembolic Disease

Trial Locations (1)

95128

Santa Clara Valley Medical Center, Santa Clara

Sponsors

Lead Sponsor

Cipherome, Inc.

All Listed Sponsors

collaborator

Santa Clara Valley Medical Center

OTHER

lead

Cipherome, Inc.

INDUSTRY

NCT03894878 - Association Between Genetic Variant Scores and Warfarin Effect | Biotech Hunter | Biotech Hunter